India-based Sun Pharmaceutical Industries Ltd (Sun Pharma), a global pharmaceutical company headquartered in Mumbai, is planning to open branch office and to expand its business in Myanmar, according to the reports.
The Directorate of Investment and
Companies Administration-DICA has already granted permission of Sun
Pharma company registration (Interim) on July 30th to expend its
pharmaceutical services in Myanmar.
The company is now discussing with the
officials from DICA matters on required law, by-law, and the rules and
regulation of the investment.
Sun Pharmaceutical Industries Ltd is one
of the biggest pharmacy companies in India, manufacturing 500 kinds of
products and producing between 25 to 30 new medicines yearly. The
company was founded in 1983 and is exporting and selling medicines to
various countries including the US and Europe.
The company is one of the leading
pharmacies in medical fields such as Psychiatry, Neurology, Cardiology,
Orthopedics, Ophthalmology, Gastroenterology and Nephrology.
In the past, the pharmaceutical factories owned by the government had been allowed the permission of medicine production.
Myanmar Investment Commission (MIC) laid
down a policy concerning the manufacturing of medicines in accordance
to international standards because medicine plays a vital role for
saving human lives.
source: Eleven Myanmar
No comments:
Post a Comment